Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease

Journal of Clinical Immunology

Volumn 33, Issue 8, 2013, Pages 1276-1284

  Battersby, A C ^a,d   Cale, C M ^b   Goldblatt, D ^c   Gennery, A R ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Chronic granulomatous disease; primary immunodeficiency; X linked carriers

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; AUTOIMMUNITY; CHORIORETINITIS; CHRONIC GRANULOMATOUS DISEASE; CLINICAL FEATURE; CYBB GENE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GASTROINTESTINAL DISEASE; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; MUTATOR GENE; ONSET AGE; PATIENT ASSESSMENT; PRIORITY JOURNAL; RECURRENT INFECTION; SKIN DISEASE; X CHROMOSOME LINKED DISORDER;

GRANULOMATOUS DISEASE, CHRONIC; HETEROZYGOTE DETECTION; HUMANS; LUPUS ERYTHEMATOSUS, DISCOID; NADPH OXIDASE; NEUTROPHILS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY BURST;

EID: 84889009074     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-013-9939-5     Document Type: Article

References (52)

1. Roos D, de Boer M, Kuribayashi F, Meischl C, Weening RS, Segal AW, et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood. 1996;87(5):1663-81.
2. Kuhns D, Alvord WG, Heller TH, Feld JJ, Pike KM, Marciano BE, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med. 2010;363(27):2600-10.
3. Roesler J, Emmendorffer A. Diagnosis of chronic granulomatous disease. Blood. 1991;78:1387-9.
4. Jelsness-Jorgensen L-P et al. Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflamm Bowel Dis. 2011;17(7):1564-72.
5. Vowells S, Sekhsaria S, Malech HL, Shalit M, Fleisher TA. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods. 1995;178:89-97.
6. Sillevis Smitt J, Weening RS, Krieg SR, Bos JD. Discoid lupus erythematosus-like lesions in carriers of X-linked chronic granulomatous disease. Br J Dermatol. 1990;122(5):643-50.
7. Brandrup F, Koch C, Petri M, et al. Discoid lupus erythematosus-like lesions and stomatitis in female carriers of X-linked chronic granulomatous disease. Br J Dermatol. 1981;104:495-505.
8. Foti C, Cassano N, Martire B, Filotico R, Mastrandrea V, Vena G. Lupus erythematosus-like lesions in a carrier of X-linked chronic graulomatous disease: a case report and personal considerations. Int J Dermatol. 2004;43(11):840-2.
9. Cale CM, Morton L, Goldblatt D. Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology. Clin Exp Immunol. 2007;148:79-84.
10. Thompson EN. Chronic granulomatous disease - quantitative clinicopathological relationships. Arch Dis Child. 1970;45(239):24.
11. Garioch J, Sampson JR, Seywright T, Thomson J. Dermatoses in five related female carriers of X-linked chronic granulomatous disease. Br J Dermatol. 1989;121:391-6.
12. Ortiz-Romero P, Corell-Almuzara A, Lopez-Estebaranz JL, Arranz FR, Ruiz-Contreras J. Lupus like lesions in a patient with X-linked chronic granulomatous disease and recombinant X chromosome. Dermatology. 1997;195(3):280-3.
13. Humbert J, Fishman CB, Western WL, et al. Frequency of carrier state for X-linked chronic granulomatous disease among females with lupus erythematosus. Clin Genet. 1976;10(1):16-20.
14. Vanderpump MPJ et al. The incidence of thyroid-disorders in the community- a 20 year follow-up of the Whickham survey. Clin Endocrinol. 1995;43(1):55-68.
15. Kragballe K, Borregaard N, Brandrup F, Koch C, et al. Relation of monocyte and neutrophil oxidative metabolism to skin and oral lesions in carriers of chronic granulomatous disease. Clin Exp Immunol. 1981;43:390-8.
16. Rösen-Wolff A, Soldan W, Heyne K, Bickhardt J, Gahr M, Roesler J. Increased susceptibility of a carrier of X-linked chronic granulomatous disease (CGD) to Aspergillus fumigatus infection associated with age-related skewing of lyonization. Ann Hematol. 2001;80:113-5.
17. Schäppi MG, Smith VV, Goldblatt D, Lindley KJ, Milla PJ. Colitis in chronic granulomatous disease. Arch Dis Child. 2001;84:147-51.
18. Sloan JM, Cameron CHS, Maxwell RJ, McCluskey DR, Collins JSA. Colitis complicating chronic granulomatous disease. A clinicopathological case report. Gut. 1996;38:619-22.
19. Marciano B, Rosenzweig SD, Holland SM, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114(2):462-8.
20. Moltanyer Y, Geerts WH, Chamberlain DW, Heyworth PG, Noack D, Rae J, et al. Underlying chronic granulomatous disease in a patient with bronchocentric granulomatosis. Thorax. 2003;58:1096-8.
21. Jaggi P, Scherzer R, Knieper R, Mousa H, Prasad V. Utility of screening for chronic granulomatous disease in patients with inflammatory. Bowel Dis J Clin Immunol. 2011;32(1):78-81.
22. Worsaae N, Staehr Johansen K, Christensen KC. Impaired in vitro function of neutrophils in Crohns disease. Scand J Gastroenterol. 1982;17(1):91-6.
23. Emmendörffer A et al. Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions. Cytometry. 1994;18(3):147-55.
24. Amos E. Immune deficiency and autoimmunity. Autoimmun Rev. 2003;2(6):364-9.
25. De Ravin S, Naumann N, Cowen EW, Friend J, Hilligoss D, Marquesen M, et al. Chronic granulomatous disease as a risk factor for autoimmune disease. J Allergy Clin Immunol. 2008;122(6):1097-103.
26. Yeaman G, Froebel K, Galea G, Ormerod A, Urbaniak SJ. Discoid lupus erythematosus in an X-linked cytochrome-positive carrier of chronic granulomatous disease. Br J Dermatol. 1992;126:60-5.
27. Cordoba-Guijarro S, Feal C, Dauden E, Fraga J, Garcia-Diez A. Lupus erythematous-like lesions in a carrier of X-linked chronic granulomatous disease. J Eur Acad Dermatol Venereol. 2010;14(5):409-11.
28. Martin-Villa J, Corell A, Ramos-Amador J, Ruiz-Contreras J, Arnaiz-Villena A. Higher incidence of autoantibodies in X-linked chronic granulomatous disease carriers: random X-chromosome inactivation may be related to autoimmunity. Autoimmunity. 1999;31:261-4.
29. Wolach B et al. Unusual late presentation of X-linked chronic granulomatous disease in an adult female with a somatic mosaic for a novel mutation in CYBB. Blood. 2005;105(1):61-6.
30. Martyn L, Lischner HW, Pileggi AJ, Harley RD. Chorioretinal lesions in familial chronic granulomatous disease of childhood. Trans Am Ophthalmol Soc. 1971;69:84-112.
31. Seong-Joon K, Joong Gon K, Young Suk Y. Chorioretinal lesions in patients with chronic granulomatous disease. Retina. 2003;23(3):360-5.
32. Valluri S, Chu FC, Smith ME. Ocular pathological findings of chronic granulomatous disease of childhood. Am J Ophthalmol. 1995;120(1):120-3.
33. Goldblatt D, Butcher J, Thrasher A, Russell-Eggitt I. Chorioretinal lesions in patients and carriers of chronic granulomatous disease. J Pediatr. 1999;134(6):780-3.
34. Boelaert K, Franklyn JA. Thyroid hormone in health and disease. J Endocrinol. 2005;187(1):1-15.
35. Lewis E, Singla M, Sergeant S, Koty PP, McPhail LC. X-Linked chronic granulomatous disease secondary to skewed X chromosome inactivation in a female with a novel CYBB mutation and late presentation. Clin Immunol. 2008;129:372-80.
36. Chollet-Martin S, Lopez A, Gaud C, Henry D, Stos B, El Benna J, et al. Severe X-linked chronic granulomatous disease in two unrelated females. Eur J Pediatr. 2007;166:153-9.
37. Lun A, Roesler J, Renz H. Unusual late onset of X-linked chronic granulomatous disease in an adult woman after unsuspicious childhood. Clin Chem. 2002;48:780-1.
38. Barton L, Johnson CR. Discoid lupus erythematosus and X-linked chronic granulomatous disease. Pediatr Dermatol. 1986;3(5):376-9.
39. Moelleri RC, Weinberg AN. Persistent salmonella infection in a female carrier for chronic granulomatous disease. Ann Intern Med. 1970;73(4):595.
40. Weening RS et al. Clinical differences in chronic granulomatous disease in patients with cytochrome-b-negative or cytochrome-b-positive neutrophils. J Pediatr. 1985;107(1):102-4.
41. Winkelstein JA et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155-69.
42. Gutierrez MJ et al. Residual NADPH oxidase activity and isolated lung involvement in x-linked chronic granulomatous disease. Case Rep Pediatr. 2012;974561(10):5.
43. Morte S et al. Production of interleukin-1 by peripheral blood mononuclear cells in patients with chronic fatigue syndrome. J Infect Dis. 1989;159(2):362.
44. Jendrossek V et al. An in-frame triplet deletion within the gp91-phox gene in an adult X-linked chronic granulomatous disease patient with residual NADPH-oxidase activity. Eur J Haematol. 1997;58(2):78-85.
45. Foster C, Lehrnbecher T, Mol F, et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest. 1998;102:2146-55.
46. Hinz A et al. Fatigue in patients with sarcoidosis, compared with the general population. Gen Hosp Psychiatry. 2011;33(5):462-8.
47. Martinez-Zamora MA, Cervera R, Balasch J. Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease. Clin Rev Allergy Immunol. 2012;43(3):265-74.
48. Roesler J. Carriers of X-linked chronic granulomatouse disease at risk. Clin Immunol. 2009;130:233.
49. Hafner J, Enderlin A, Seger RA, Wuthrich B, Bruckner-Tudermann, Panizzoni P, et al. Discoid lupus erythematosus-like lesions in carriers of X-linked chronic granulomatous disease. Br J Dermatol. 1992;127:446-7.
50. Lovas J, Issekutz A, Walsh N, Miller RAW. Lupus erythematosus-like oral mucosal and skin lesions in a carrier of chronic granulomatous disease. Oral Surg Oral Med Oral Pathol. 1995;80(1):78-82.
51. Rupec R, Petropoulou TH, Belohradsky BH, et al. Lupus erythematosus tumidus and chronic discoid lupus erythematosus in carriers of X-linked chronic granulomatous disease. Eur J Dermatol. 2000;10(3):184-9.
52. Johnston RB, Harbeck RJ. Recurrent severe infections in a girl with apparently variable expression of mosaicism for chronic granulomatous disease. J Pediatr. 1985;106(1):50-5.